Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: --
257,95 DKK
Kurs
Kurs
0,02%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
533,40 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 17.04.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 257,95 250 | 257,95 | 250 | 3,081993 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 257,95 332 | 257,95 | 332 | 28,707114 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 257,95 263 | 257,95 | 263 | 1,957744 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 257,95 250 | 257,95 | 250 | 3,081993 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 257,95 275 | 257,95 | 275 | 6,609808 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 257,95 250 | 257,95 | 250 | 3,081993 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 257,95 300 | 257,95 | 300 | 16,301609 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 257,95 250 | 257,95 | 250 | 3,081993 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 257,95 260 | 257,95 | 260 | 0,794728 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 257,95 400 | 257,95 | 400 | 55,068812 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 257,95 250 | 257,95 | 250 | 3,081993 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 257,95 400 | 257,95 | 400 | 55,068812 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 257,95 332 | 257,95 | 332 | 28,707114 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 257,95 340 | 257,95 | 340 | 31,80849 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 257,95 275 | 257,95 | 275 | 6,609808 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 257,95 350 | 257,95 | 350 | 35,68521 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 257,95 340 | 257,95 | 340 | 31,80849 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 257,95 275 | 257,95 | 275 | 6,609808 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 257,95 250 | 257,95 | 250 | 3,081993 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 257,95 340 | 257,95 | 340 | 31,80849 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 257,95 340 | 257,95 | 340 | 31,80849 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 257,95 340 | 257,95 | 340 | 31,80849 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 257,95 340 | 257,95 | 340 | 31,80849 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 257,95 400 | 257,95 | 400 | 55,068812 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 257,95 275 | 257,95 | 275 | 6,609808 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 257,95 360 | 257,95 | 360 | 39,561931 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 257,95 360 | 257,95 | 360 | 39,561931 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 257,95 360 | 257,95 | 360 | 39,561931 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 257,95 350 | 257,95 | 350 | 35,68521 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 257,95 332 | 257,95 | 332 | 28,707114 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 257,95 475 | 257,95 | 475 | 84,144214 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 257,95 332 | 257,95 | 332 | 28,707114 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 257,95 350 | 257,95 | 350 | 35,68521 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 257,95 350 | 257,95 | 350 | 35,68521 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 257,95 350 | 257,95 | 350 | 35,68521 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 257,95 360 | 257,95 | 360 | 39,561931 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 257,95 390 | 257,95 | 390 | 51,192091 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 257,95 350 | 257,95 | 350 | 35,68521 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 257,95 436 | 257,95 | 436 | 69,025005 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 257,95 415 | 257,95 | 415 | 60,883892 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 257,95 360 | 257,95 | 360 | 39,561931 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 257,95 390 | 257,95 | 390 | 51,192091 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 257,95 390 | 257,95 | 390 | 51,192091 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 257,95 360 | 257,95 | 360 | 39,561931 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 257,95 415 | 257,95 | 415 | 60,883892 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 257,95 475 | 257,95 | 475 | 84,144214 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 257,95 350 | 257,95 | 350 | 35,68521 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 257,95 390 | 257,95 | 390 | 51,192091 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 257,95 400 | 257,95 | 400 | 55,068812 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 257,95 400 | 257,95 | 400 | 55,068812 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 257,95 360 | 257,95 | 360 | 39,561931 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 257,95 350 | 257,95 | 350 | 35,68521 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 257,95 475 | 257,95 | 475 | 84,144214 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 257,95 350 | 257,95 | 350 | 35,68521 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 257,95 475 | 257,95 | 475 | 84,144214 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 257,95 295 | 257,95 | 295 | 14,363249 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 257,95 295 | 257,95 | 295 | 14,363249 | UBS | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 257,95 350 | 257,95 | 350 | 35,68521 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 257,95 352 | 257,95 | 352 | 36,460554 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 257,95 400 | 257,95 | 400 | 55,068812 | BERENBERG | ||
| Novo Nordisk AS | 03.12.2025 0 Monate | 03.12.2025 | 0 Monate | 257,95 295 | 257,95 | 295 | 14,363249 | UBS | ||
| Novo Nordisk AS | 30.11.2025 0 Monate | 30.11.2025 | 0 Monate | 257,95 270 | 257,95 | 270 | 4,671448 | JEFFERIES | ||
| Novo Nordisk AS | 28.11.2025 12 Monate | 28.11.2025 | 12 Monate | 257,95 375 | 257,95 | 375 | 45,377011 | BARCLAYS | ||
| Novo Nordisk AS | 28.11.2025 0 Monate | 28.11.2025 | 0 Monate | 257,95 315 | 257,95 | 315 | 22,116689 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 257,95 475 | 257,95 | 475 | 84,144214 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.11.2025 12 Monate | 26.11.2025 | 12 Monate | 257,95 353 | 257,95 | 353 | 36,848226 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 257,95 475 | 257,95 | 475 | 84,144214 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 25.11.2025 0 Monate | 25.11.2025 | 0 Monate | 257,95 500 | 257,95 | 500 | 93,836015 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 257,95 500 | 257,95 | 500 | 93,836015 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 257,95 290 | 257,95 | 290 | 12,424889 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 257,95 375 | 257,95 | 375 | 45,377011 | BARCLAYS | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 257,95 391 | 257,95 | 391 | 51,579764 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.11.2025 0 Monate | 24.11.2025 | 0 Monate | 257,95 | 257,95 | -- | DZ BANK | |||
| Novo Nordisk AS | 17.11.2025 0 Monate | 17.11.2025 | 0 Monate | 257,95 315 | 257,95 | 315 | 22,116689 | UBS | ||
| Novo Nordisk AS | 13.11.2025 0 Monate | 13.11.2025 | 0 Monate | 257,95 400 | 257,95 | 400 | 55,068812 | BERENBERG | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 257,95 475 | 257,95 | 475 | 84,144214 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 257,95 600 | 257,95 | 600 | 132,603218 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 257,95 | 257,95 | -- | DZ BANK | |||
| Novo Nordisk AS | 10.11.2025 0 Monate | 10.11.2025 | 0 Monate | 257,95 315 | 257,95 | 315 | 22,116689 | UBS | ||
| Novo Nordisk AS | 07.11.2025 0 Monate | 07.11.2025 | 0 Monate | 257,95 315 | 257,95 | 315 | 22,116689 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 257,95 600 | 257,95 | 600 | 132,603218 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 257,95 391 | 257,95 | 391 | 51,579764 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.11.2025 0 Monate | 06.11.2025 | 0 Monate | 257,95 540 | 257,95 | 540 | 109,342896 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 257,95 290 | 257,95 | 290 | 12,424889 | JEFFERIES | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 257,95 500 | 257,95 | 500 | 93,836015 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 12 Monate | 05.11.2025 | 12 Monate | 257,95 500 | 257,95 | 500 | 93,836015 | JPMORGAN |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 06.05.2026 | Bericht zum 1. Quartal Novo Nordisk A/S: First quarter 2026 | Novo Nordisk A/S: First quarter 2026 |
| 05.08.2026 | Bericht zum 2. Quartal Novo Nordisk A/S: Second quarter 2026 | Novo Nordisk A/S: Second quarter 2026 |
DZ BANK Produktauswahl
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M